Literature DB >> 29210193

Islet damage during isolation as assessed by miRNAs and the correlation of miRNA levels with posttransplantation outcome in islet autotransplantation.

Prathab Balaji Saravanan1, Mazhar A Kanak2, Charles A Chang3, Carly Darden3, Gumpei Yoshimatsu1, Michael C Lawrence1, Bashoo Naziruddin4.   

Abstract

High-quality pancreatic islets are essential for better posttransplantation endocrine function in total pancreatectomy with islet autotransplantation (TPIAT), yet stress during the isolation process affects quality and yield. We analyzed islet-enriched microRNAs (miRNAs) -375 and -200c released during isolation to assess damage and correlated the data with posttransplantation endocrine function. The absolute concentration of miR-375, miR-200c, and C-peptide was measured in various islet isolation steps, including digestion, dilution, recombination, purification, and bagging, in 12 cases of TPIAT. Posttransplantation glycemic control was monitored through C-peptide, hemoglobin A1c , insulin requirement, and SUITO index. The amount of miR-375 released was significantly higher during enzymatic digestion followed by the islet bagging (P < .001). Mir-200c mirrored these changes, albeit at lower concentrations. In contrast, the C-peptide amount was significantly higher in the purification and bagging steps (P < .001). Lower amounts of miR-375 were associated with a lower 6-month insulin requirement (P = .01) and lower hemoglobin A1c (P = .04). Measurement of the absolute quantity of miRNA-375 and -200c released during islet isolation is a useful tool to assess islet damage. The quantity of released miRNA is indicative of posttransplantation endocrine function in TPIAT patients.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  autotransplantation; basic (laboratory) research / science; biomarker; clinical research / practice; diabetes; endocrinology / diabetology; islet isolation; islet transplantation

Mesh:

Substances:

Year:  2018        PMID: 29210193     DOI: 10.1111/ajt.14615

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Engineering islets from stem cells for advanced therapies of diabetes.

Authors:  Johanna Siehler; Anna Karolina Blöchinger; Matthias Meier; Heiko Lickert
Journal:  Nat Rev Drug Discov       Date:  2021-08-10       Impact factor: 84.694

2.  Differential expression and release of exosomal miRNAs by human islets under inflammatory and hypoxic stress.

Authors:  Prathab Balaji Saravanan; Srividya Vasu; Gumpei Yoshimatsu; Carly M Darden; Xuan Wang; Jinghua Gu; Michael C Lawrence; Bashoo Naziruddin
Journal:  Diabetologia       Date:  2019-08-01       Impact factor: 10.122

3.  Assessment of Culture/Preservation Conditions of Human Islets for Transplantation.

Authors:  Yoshitaro Shindo; Jagan Kalivarathan; Prathab Balaji Saravanan; Marlon F Levy; Mazhar A Kanak
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

Review 4.  A comprehensive overview on Micro RNA signature in type 2 diabetes Mellitus and its complications.

Authors:  Sanjukta Mishra; Jyotirmayee Bahinipati; RajLaxmi Sarangi; Soumya Ranjan Mohapatra; Swarnalata Das; Amaresh Mishra
Journal:  Indian J Clin Biochem       Date:  2022-09-05

Review 5.  Building Biomimetic Potency Tests for Islet Transplantation.

Authors:  Aaron L Glieberman; Benjamin D Pope; Douglas A Melton; Kevin Kit Parker
Journal:  Diabetes       Date:  2021-02       Impact factor: 9.461

Review 6.  Redox-Dependent Inflammation in Islet Transplantation Rejection.

Authors:  Jessie M Barra; Hubert M Tse
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

7.  Circulating miRNA in Patients Undergoing Total Pancreatectomy and Islet Autotransplantation.

Authors:  Srividya Vasu; Jiemin M Yang; James Hodges; Maisam A Abu-El-Haija; David B Adams; Appakalai N Balamurugan; Greg J Beilman; Srinath Chinnakotla; Darwin L Conwell; Martin L Freeman; Timothy B Gardner; Betul Hatipoglu; Varvara Kirchner; Luis F Lara; Katherine A Morgan; Jaimie D Nathan; Andrew Posselt; Timothy L Pruett; Sarah J Schwarzenberg; Vikesh K Singh; Martin Wijkstrom; Piotr Witkowski; Bashoo Naziruddin; Melena D Bellin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.